Efficacy and safety of combined medium-dose mometasone furoate/formoterol (MF/F) in persistent asthmatics

Efficacy and safety of combined medium-dose mometasone furoate/formoterol (MF/F) in persistent asthmatics

Bibliographic Details
Main Authors:	Nathan Robert A, Pearlman David S, Nolte Hendrik, Nayak Anjuli
Format:	Article
Language:	English
Published:	BMC 2010-11-01
Series:	Allergy, Asthma & Clinical Immunology

Similar Items

Efficacy and safety of medium and high doses of mometasone furoate/formoterol (MF/F) combination treatment in subjects with severe persistent asthma
by: Weinstein Steven F, et al.
Published: (2010-12-01)

Effect of mometasone furoate/formoterol combination therapy on nocturnal awakenings in subjects with persistent asthma
by: Pearlman David, et al.
Published: (2011-11-01)

Non-inferiority efficacy comparison of mometasone furoate/formoterol versus fluticasone propionate/salmeterol combination therapies in subjects with persistent asthma
by: Bernstein David I, et al.
Published: (2010-12-01)

Efficacy and onset of action of mometasone furoate/formoterol and fluticasone propionate/salmeterol combination treatment in subjects with persistent asthma
by: Bernstein David I, et al.
Published: (2011-12-01)

Efficacy and safety of mometasone furoate/formoterol combination in patients with bronchial asthma
by: A. V. Emelyanov
Published: (2015-12-01)

Comparison of the systemic bioavailability of mometasone furoate after oral inhalation from a mometasone furoate/formoterol fumarate metered-dose inhaler versus a mometasone furoate dry-powder inhaler in patients with chronic obstructive pulmonary disease
by: Kosoglou T, et al.
Published: (2013-03-01)

Efficacy of Mometasone Furoate and Fluticasone Furoate on Persistent Allergic Rhinoconjunctivitis
by: W. Hamizan Aneeza M.S., et al.
Published: (2013-09-01)

Reduction in asthma deteriorations in subjects with persistent asthma uncontrolled on low-, medium-, or high-dose inhaled corticosteroids: a pooled analysis from three clinical trials using combined mometasone furoate/formoterol
by: Weinstein SF, et al.
Published: (2011-11-01)

Mometasone furoate/formoterol combination therapy increases frequency of days/nights free of short-acting β<sub>2</sub>-agonist use
by: Nayak AS, et al.
Published: (2011-11-01)

Development of simple and fast UV-method for the quantitative determination of mometasone furoate in a large number of metered doses of an aqueous nasal spray of mometasone furoate
by: Mykhaylo Levin, et al.
Published: (2019-11-01)

Forced degradation of mometasone furoate and development of two RP-HPLC methods for its determination with formoterol fumarate or salicylic acid
by: Ramzia I. El-Bagary, et al.
Published: (2016-05-01)

Mometasone furoate in the management of asthma: a review
by: Ricardo A Tan, et al.
Published: (2008-09-01)

Mometasone Furoate Improves Nasal and Ocular Symptoms of Seasonal Allergic Rhinitis in Adolescents
by: Robert Anolik M.D., et al.
Published: (2010-01-01)

Mometasone furoate is not superior to saline for chronic rhinitis in the elderly
by: Victor Carvalho, et al.
Published: (2019-10-01)

Evaluation of the safety and efficacy of topical mometasone furoate formulations
by: Chamboko, Bernadett Vongayi
Published: (2007)

Long-term safety of Mometasone Furoate administered via a dry powder inhaler in children: Results of an open-label study comparing Mometasone Furoate with Beclomethasone Dipropionate in children with persistent asthma
by: Corren Jonathan, et al.
Published: (2009-07-01)

EFFECTIVENESS OF MOMETASONE FUROATE IN TREATMENT OF PALATINE TONSIL HYPERTROPHY IN CHILDREN
by: E.V. Nosulya, et al.
Published: (2009-05-01)

EFFICACY AND SAFETY OF USING MOMETASONE FUROATE IN CHILDREN WITH ATOPIC DERMATITIS
by: A.Yu. Tomilova, et al.
Published: (2009-08-01)

EFFICACY AND SAFETY OF USING MOMETASONE FUROATE IN CHILDREN WITH ATOPIC DERMATITIS
by: A.Yu. Tomilova, et al.
Published: (2009-08-01)

Comparison of montelukast and mometasone furoate in the prevention of recurrent nasal polyps
by: Erkan Vuralkan, et al.
Published: (2012-02-01)

Assessment of Patient Attitudes About Mometasone Furoate Nasal Spray
by: Leonard M. Fromer, et al.
Published: (2008-01-01)

EFFECTIVENESS OF MOMETASONE FUROATE IN TREATMENT OF PALATINE TONSIL HYPERTROPHY IN CHILDREN
by: E.V. Nosulya, et al.
Published: (2009-01-01)

A Patient Preference Study that Evaluated Fluticasone Furoate and Mometasone Furoate Nasal Sprays for Allergic Rhinitis
by: Anahi Yanez M.D., et al.
Published: (2016-10-01)

Suppression of cytokine release by fluticasone furoate vs. mometasone furoate in human nasal tissue ex-vivo.
by: Nan Zhang, et al.
Published: (2014-01-01)

Mometasone furoate and fluticasone furoate are equally effective in restoring nasal epithelial barrier dysfunction in allergic rhinitis
by: Maria Doulaptsi, et al.
Published: (2021-09-01)

Efficacy and safety of a fixed-dose combination of mometasone furoate and formoterol fumarate in subjects with moderate to very severe COPD: results from a 52-week Phase III trial
by: Tashkin DP, et al.
Published: (2012-02-01)

One-year treatment with mometasone furoate in chronic obstructive pulmonary disease
by: Abbate Eduardo H, et al.
Published: (2008-11-01)

Significant receptor affinities of metabolites and a degradation product of mometasone furoate
by: Högger Petra, et al.
Published: (2004-07-01)

Mometasone furoate in the treatment of mild, moderate, or severe persistent allergic rhinitis: a non-inferiority study (PUMA)
by: Martti Anton Antila, et al.

Мometasone furoate/formoterol: new fixed-dose combination in the treatment of bronchial asthma
by: A. V. Еmelyanov
Published: (2013-12-01)

Pharmacokinetics of indacaterol, glycopyrronium and mometasone furoate administered as an inhaled fixed-dose combination in Japanese and Caucasian healthy subjects
by: Satoru Inoue, et al.
Published: (2021-01-01)

Triple combination of hydroquinone, tretinoin and mometasone furoate with glycolic acid peels in melasma
by: Godse Kiran
Published: (2009-01-01)

Evaluation of rheological and mucoadhesive properties of selected nasal spray preparations with mometasone furoate
by: Emilia Szymańska, et al.
Published: (2017-06-01)

Efficacy and safety characteristics of mometasone furoate/formoterol fumarate fixed-dose combination in subjects with moderate to very severe COPD: findings from pooled analysis of two randomized, 52-week placebo-controlled trials
by: Tashkin DP, et al.
Published: (2012-02-01)

Effects of mometasone furoate/formoterol fumarate fixed-dose combination formulation on chronic obstructive pulmonary disease (COPD): results from a 52-week Phase III trial in subjects with moderate-to-very severe COPD
by: Doherty DE, et al.
Published: (2012-02-01)

Influence of tacrolimus combined mometasone furoate on serum inflammatory factors and immune function in children with eczema
by: Yang Wu, et al.
Published: (2017-07-01)

Development, stability and in vitro permeation studies of gels containing mometasone furoate for the treatment of dermatitis of the scalp
by: Ana Cristina Gomes Barros Salgado, et al.
Published: (2010-03-01)

Treatment Evaluation with Mometasone Furoate, Alone or in Combination with Desloratadine/ Montelukast in Moderate Severe Allergic Rhinitis
by: Florincescu-Gheorghe Nona-Aura, et al.
Published: (2014-06-01)

Lung function improvements following inhaled indacaterol/glycopyrronium/mometasone furoate are independent of dosing time in asthma patients: a randomised trial
by: Jutta Beier, et al.
Published: (2021-04-01)

Set-up of a method using LC-UV to assay mometasone furoate in pharmaceutical dosage forms
by: Aline Ferreira Ourique, et al.
Published: (2012-01-01)